You just read:

Sirnaomics Received IND Approval from CFDA for Its Leading siRNA Therapeutic Candidate, STP705, for Treatment of Hypertrophic Scar

News provided by

Sirnaomics, Inc.

May 01, 2017, 11:22 ET